PHILADELPHIA, May 27 /PRNewswire/ --
- Dillon to Lead Effort to Deliver Trusted Clinical Knowledge via Evidence-based Content and Powerful Analytics
Elsevier, the leading publisher of scientific, technical and medical information, announced today that Chris Dillon has joined Elsevier Health Sciences as Managing Director for the Clinical Decision Support (CDS) group. Dillon will assume responsibility for all CDS operations and strategy, including product development, marketing and sales. He will provide overall vision to further the CDS mission to help healthcare organizations improve outcomes, streamline workflow and enhance care.
Chris's impressive track record of running successful technology-enabled healthcare businesses and his ability to anticipate the needs of healthcare organizations and professionals across disciplines will be indispensable, said Michael Hansen, Chief Executive Officer, Elsevier Health Sciences. Chris will help lead our efforts to achieve Elsevier's mission to deliver accurate, evidence-based, interactive and consistent answers to clinical questions, whenever and wherever the need arises.
CDS is Elsevier Health Sciences' point-of-care, payer, provider and eLearning business unit, offering solutions for every member of the healthcare team, from providers (physicians, nurses, pharmacists, allied health professionals and educators) to administrators in finance and operations. Working with feedback from customers, Dillon will help the CDS business unit to refine Elsevier's knowledge solutions - from drug information and interactive task guidance to care planning and process improvement - so all clinical professionals receive the information they need to make critical diagnostic and therapeutic decisions.
Dillon brings more than 30 years of experience in marketing, management and sales of healthcare products and services to Elsevier's CDS unit. Most recently, he was Senior Vice President of Marketing at Misys Healthcare Systems, a leading physician practice EMR provider, where he implemented go-to-market strategies. He also served as the Vice President/General Manager of McKesson's specialty business, which provides physicians with distribution, technology and clinical and educational solutions.
Before his tenure at McKesson, Dillon headed strategic product support at Biogen, a company involved in the discovery, development, manufacturing and commercialization of innovative therapies. Dillon started his career at Johnson Johnson, where he spent 16 years in varied sales and management positions. He received a BS in Business Administration from Ohio State University.
About Elsevier
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier's 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect (http://www.sciencedirect.com/), MD Consult (http://www.mdconsult.com/), Scopus (http://www.info.scopus.com/), bibliographic databases, and online reference works.
Elsevier (http://www.elsevier.com/) is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc (http://www.reedelsevier.com/), a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Tom Reller Director, Corporate Relations +1-212-462-1912 T.Reller@Elsevier.com
Tom Reller, Director, Corporate Relations, +1-212-462-1912, T.Reller@Elsevier.com
Comments